The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Odink Debra since 2010.
The trader's CIK number is 1281719.
At the time of the last reporting, Odink Debra was the VP, Pharmaceutical R&D of Anthera Pharmaceuticals Inc. (stock ticker symbol ANTH).
Also see all insider trading activities at Anthera Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | ANTH | 0 | $0 | 1,205 | $7,410 | 0 | $0 |
2012 | ANTH | 0 | $0 | 6,000 | $41,485 | 0 | $0 |
2011 | ANTH | 0 | $0 | 0 | $0 | 3,311 | $4,999 |
2010 | ANTH | 1,000 | $4,200 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-10-12 | ANTH | Sale | 1,205 | 6.15 | 7,410 |
2012-03-01 | ANTH | Sale | 2,000 | 6.57 | 13,140 |
2012-02-01 | ANTH | Sale | 2,000 | 7.67 | 15,340 |
2012-01-10 | ANTH | Sale | 800 | 6.51 | 5,205 |
2012-01-06 | ANTH | Sale | 1,200 | 6.50 | 7,800 |
2011-04-13 | ANTH | Option Ex | 3,311 | 1.51 | 4,999 |
2010-09-24 | ANTH | Buy | 1,000 | 4.20 | 4,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Odink Debra (VP, Pharmaceutical R&D of Anthera Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.